Literature DB >> 23452376

The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.

Alexander C Theos1, Brenda Watt, Dawn C Harper, Karolina J Janczura, Sarah C Theos, Kathryn E Herman, Michael S Marks.   

Abstract

Proteolytic fragments of the pigment cell-specific glycoprotein, PMEL, form the amyloid fibrillar matrix underlying melanins in melanosomes. The fibrils form within multivesicular endosomes to which PMEL is selectively sorted and that serve as melanosome precursors. GPNMB is a tissue-restricted glycoprotein with substantial sequence homology to PMEL, but no known function, and was proposed to localize to non-fibrillar domains of distinct melanosome subcompartments in melanocytes. Here we confirm that GPNMB localizes to compartments distinct from the PMEL-containing multivesicular premelanosomes or late endosomes in melanocytes and HeLa cells, respectively, and is largely absent from fibrils. Using domain swapping, the unique PMEL localization is ascribed to its polycystic kidney disease (PKD) domain, whereas the homologous PKD domain of GPNMB lacks apparent sorting function. The difference likely reflects extensive modification of the GPNMB PKD domain by N-glycosylation, nullifying its sorting function. These results reveal the molecular basis for the distinct trafficking and morphogenetic properties of PMEL and GPNMB and support a deterministic function of the PMEL PKD domain in both protein sorting and amyloidogenesis.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23452376      PMCID: PMC3695043          DOI: 10.1111/pcmr.12084

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  69 in total

1.  A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature.

Authors:  J F Berson; D W Frank; P A Calvo; B M Bieler; M S Marks
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

2.  Scanning transmission X-ray microscopic analysis of purified melanosomes of the mouse iris.

Authors:  Michael G Anderson; Tamás Haraszti; Greg E Petersen; Sue Wirick; Chris Jacobsen; Simon W M John; Michael Grunze
Journal:  Micron       Date:  2006-04-18       Impact factor: 2.251

Review 3.  Melanosomes--dark organelles enlighten endosomal membrane transport.

Authors:  Graça Raposo; Michael S Marks
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

4.  The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers.

Authors:  Toshihiko Hoashi; Jacqueline Muller; Wilfred D Vieira; Francois Rouzaud; Kanako Kikuchi; Kunihiko Tamaki; Vincent J Hearing
Journal:  J Biol Chem       Date:  2006-05-08       Impact factor: 5.157

5.  A model for melanosome biogenesis based on the purification and analysis of early melanosomes.

Authors:  T Kushimoto; V Basrur; J Valencia; J Matsunaga; W D Vieira; V J Ferrans; J Muller; E Appella; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

6.  Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17.

Authors:  Alexander C Theos; Joanne F Berson; Sarah C Theos; Kathryn E Herman; Dawn C Harper; Danièle Tenza; Elena V Sviderskaya; M Lynn Lamoreux; Dorothy C Bennett; Graça Raposo; Michael S Marks
Journal:  Mol Biol Cell       Date:  2006-06-07       Impact factor: 4.138

7.  Sialylated core 1 O-glycans influence the sorting of Pmel17/gp100 and determine its capacity to form fibrils.

Authors:  Julio C Valencia; Francois Rouzaud; Sylvain Julien; Kevin G Chen; Thierry Passeron; Yuji Yamaguchi; Mones Abu-Asab; Maria Tsokos; Gertrude E Costin; Hiroshi Yamaguchi; Lisa M Miller Jenkins; Kunio Nagashima; Ettore Appella; Vincent J Hearing
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

8.  Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

Authors:  An Chi; Julio C Valencia; Zhang-Zhi Hu; Hidenori Watabe; Hiroshi Yamaguchi; Nancy J Mangini; Hongzhan Huang; Victor A Canfield; Keith C Cheng; Feng Yang; Riichiro Abe; Shoichi Yamagishi; Jeffrey Shabanowitz; Vincent J Hearing; Cathy Wu; Ettore Appella; Donald F Hunt
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

9.  Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts.

Authors:  Harumi Furochi; Seiko Tamura; Mai Mameoka; Chiharu Yamada; Takayuki Ogawa; Katsuya Hirasaka; Yuushi Okumura; Takahito Imagawa; Sachiko Oguri; Kazumi Ishidoh; Kyoichi Kishi; Shigeki Higashiyama; Takeshi Nikawa
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

10.  Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.

Authors:  G Raposo; D Tenza; D M Murphy; J F Berson; M S Marks
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  12 in total

Review 1.  Why Study Functional Amyloids? Lessons from the Repeat Domain of Pmel17.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  J Mol Biol       Date:  2018-06-07       Impact factor: 5.469

2.  Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Authors:  Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

3.  Amyloids, melanins and oxidative stress in melanomagenesis.

Authors:  Feng Liu-Smith; Carrie Poe; Patrick J Farmer; Frank L Meyskens
Journal:  Exp Dermatol       Date:  2014-11-18       Impact factor: 3.960

Review 4.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

5.  GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.

Authors:  G Maric; M G Annis; Z Dong; A A N Rose; S Ng; D Perkins; P A MacDonald; V Ouellet; C Russo; P M Siegel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

6.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

7.  Reversing the amyloid trend: Mechanism of fibril assembly and dissolution of the repeat domain from a human functional amyloid.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Isr J Chem       Date:  2017-01-19       Impact factor: 3.333

8.  Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.

Authors:  Chi-Fan Yang; Shuan-Pei Lin; Chien-Ping Chiang; Yu-Hung Wu; Weng Siong H'ng; Chun-Ping Chang; Yuan-Tsong Chen; Jer-Yuarn Wu
Journal:  Am J Hum Genet       Date:  2018-01-11       Impact factor: 11.025

Review 9.  Amyloidosis in alkaptonuria.

Authors:  Lia Millucci; Daniela Braconi; Giulia Bernardini; Pietro Lupetti; Josef Rovensky; Lakshminaryan Ranganath; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

10.  Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins.

Authors:  Paul W Chrystal; Tim Footz; Elizabeth D Hodges; Justin A Jensen; Michael A Walter; W Ted Allison
Journal:  Molecules       Date:  2021-06-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.